Examining the COVID-19 impact on cancer surgery in Ireland using three national data sources

Examining the COVID-19 impact on cancer surgery in Ireland using three national data sources

Background: The healthcare system in Ireland was profoundly affected by COVID-19. This study aimed to explore the impact of the pandemic on cancer surgery in Ireland, from 2019 to 2022 using three national health data sources. Methods: A repeated cross-sectional study design was used and included: (...

Full description

Saved in:
Bibliographic Details
Main Authors: Mengyang Zhang, Caitriona Kelly, Triona McCarthy, Paula Tierney, Aline Brennan, Louise Burke, Caitriona McGrath, Maeve Mullooly, Deirdre Murray, Kathleen Bennett
Format: Article
Language:English
Published: Elsevier 2024-12-01
Series:Global Epidemiology
Subjects:
cancer surgery
COVID-19
Ireland
public-private healthcare system
Online Access:http://www.sciencedirect.com/science/article/pii/S2590113324000257
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background: The healthcare system in Ireland was profoundly affected by COVID-19. This study aimed to explore the impact of the pandemic on cancer surgery in Ireland, from 2019 to 2022 using three national health data sources. Methods: A repeated cross-sectional study design was used and included: (i) cancer resections from the National Histopathology Quality Improvement (NHQI) Programmes; (ii) cancer surgery from the National Cancer Registry Ireland (NCRI), and (iii) cancer surgery from Hospital Inpatient Enquiry (HIPE) System. Cancer surgery was presented by invasive/in situ and invasive only cancers (NCRI & HIPE), and by four main cancer types (breast, lung, colorectal & melanoma for NCRI & HIPE data only). Results: The annual number of cancer resections (NHQI) declined by 4.4% in 2020 but increased by 4% in 2021 compared with 2019. NCRI data indicated invasive/in-situ cancer surgery for the four main cancer types declined by 14% in 2020 and 5.1% in 2021, and by 12.3% and 7.3% for invasive cancer only, compared to 2019. Within HIPE for the same tumour types, invasive/in situ cancer surgery declined by 21.9% in 2020 and 9.9% in 2021 and by 20.8% and 9.6% for invasive cancer only. NHQI and HIPE data indicated an increase in the number of cancer surgeries performed in 2022. Conclusions: Cancer surgery declined in the initial pandemic waves suggests mitigation measures for cancer surgery, including utilising private hospitals for public patients, reduced the adverse impact on cancer surgery.
ISSN:2590-1133

Similar Items